SCHEMBL25880354

SCHEMBL25880354

c1ccc(-c2ccc3c4c2c2ccccc2n4c2ccc(-c4ccccc4)c4c5ccccc5n3c42)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.41
HTR6 P50406 1/20 0.36
RET P07949 1/20 0.35
KDM4E B2RXH2 4/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
MAPT P10636 2/20 0.33
BRD4 O60885 1/20 0.33
PTGER1 P34995 1/20 0.33
MAPK14 Q16539 1/20 0.33
TSHR P16473 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
ATM Q13315 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
MEN1 O00255 1/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32
PARP1 P09874 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25880375 0.91 HSD17B10 (0.38) HSD17B10HTR6RETKDM4EALDH1A1
SCHEMBL25880402 0.90 HSD17B10 (0.37) HSD17B10KDM4EALDH1A1HPGDMAPT
SCHEMBL25880521 0.89 KMT2A (0.37) HSD17B10RETKDM4EALDH1A1HPGD
SCHEMBL25880382 0.89 HSD17B10 (0.36) HSD17B10KDM4EALDH1A1HPGDMAPT
SCHEMBL25880383 0.85 HSD17B10 (0.35) HSD17B10HTR6KDM4EALDH1A1HPGD
SCHEMBL25880522 0.84 ACP1 (0.37) HSD17B10KDM4EALDH1A1HPGDMAPT
SCHEMBL25880473 0.84 L3MBTL1 (0.46) RETKDM4EALDH1A1MAPTL3MBTL1
SCHEMBL20858026 0.83 HSD17B10 (0.41) HSD17B10HTR6RETKDM4EALDH1A1
SCHEMBL25880361 0.82 NPC1 (0.42) HSD17B10ALDH1A1MAPTNPC1RAB9A
SCHEMBL25880370 0.82 BRD9 (0.42) HSD17B10RETKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230240135-A1 HETEROCYLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CRY1, LAGE3, NQO1 HSD17B10 1229/4885HTR6 1319/4885RET 2698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.